GoKawiil
1.
2.
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
(feeds.content.dowjones.io)
3.
UCB to Buy Candid Therapeutics for Up to $2.2 Billion
(feeds.content.dowjones.io)
4.
Eli Lilly Strikes Deal for Cancer Biotech
(feeds.content.dowjones.io)
5.
Eli Lilly Nears Deal for Cancer Biotech
(feeds.content.dowjones.io)
6.
Neurocrine to Buy Soleno for Treatment for Rare Disease That Causes Relentless Hunger
(feeds.content.dowjones.io)
7.
Neurocrine to Buy Soleno for $2.9 Billion
(feeds.content.dowjones.io)
8.
HN: I simulated a real cancer case and predicted why some tumors didn't respond
(news.ycombinator.com)
9.
The most innovative biotech companies of 2026
(feeds.feedburner.com)
10.
A gene-editing method generates immunotherapeutic CAR T cells in the body
(feeds.nature.com)
11.
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion
(feeds.content.dowjones.io)
12.
A skin-permeable polymer for non-invasive transdermal insulin delivery
(feeds.nature.com)
Today's top topics:
cnet